Toshiya Kai
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
Papers in
-
- Protein Interaction Studies and Fluorescence Analysis 12
- Heme Oxygenase-1 and Carbon Monoxide 3
-
- Drug Solubulity and Delivery Systems 6
- Advanced Drug Delivery Systems 4
- Co-authors
- Masaki Otagiri (19 shared papers)Ken‐ichi Ogawara (3 shared papers)Kazutaka Higaki (3 shared papers)Kentaro Furumoto (2 shared papers)Makoto Anraku (6 shared papers)Ulrich Kragh‐Hansen (11 shared papers)Toru Maruyama (9 shared papers)Yu Ishima (12 shared papers)
- Journals
- European Journal of Pharmaceutical Sciences (5 papers)Chemical and Pharmaceutical Bulletin (3 papers)International Journal of Pharmaceutics (3 papers)Nitric Oxide (3 papers)Journal of Controlled Release (3 papers)
- Partner nations
- JapanDenmarkUnited States
In The Last Decade
Toshiya Kai
35 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 106
- Biomaterials 295
- Pharmaceutical Science 100
- Cell Biology 166
- Biochemistry 53
- Surfaces, Coatings and Films 51
Countries citing papers authored by Toshiya Kai
This map shows the geographic impact of Toshiya Kai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiya Kai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiya Kai more than expected).
Fields of papers citing papers by Toshiya Kai
This network shows the impact of papers produced by Toshiya Kai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiya Kai. The network helps show where Toshiya Kai may publish in the future.
Co-authors
The 25 scholars most cited alongside Toshiya Kai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 161 | |
| 2 | 2006 | 108 | |
| 3 | 2006 | 72 | |
| 4 | 2006 | 68 | |
| 5 | 2007 | 67 | |
| 6 | 2009 | 50 | |
| 7 | 2012 | 45 | |
| 8 | 2008 | 41 | |
| 9 | 2009 | 40 | |
| 10 | 2015 | 37 | |
| 11 | 2008 | 35 | |
| 12 | 2009 | 32 | |
| 13 | 1999 | 28 | |
| 14 | 2009 | 26 | |
| 15 | 2007 | 22 | |
| 16 | 2005 | 22 | |
| 17 | 2012 | 22 | |
| 18 | 1999 | 22 | |
| 19 | 2005 | 19 | |
| 20 | 2022 | 19 |
About Toshiya Kai
Toshiya Kai is a scholar working on Molecular Biology, Pharmaceutical Science, Physiology, Cell Biology and Spectroscopy, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Protein Interaction Studies and Fluorescence Analysis (12 papers), Hemoglobin structure and function (7 papers), Nitric Oxide and Endothelin Effects (7 papers), Drug Solubulity and Delivery Systems (6 papers), Lanthanide and Transition Metal Complexes (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Advanced Drug Delivery Systems (4 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). The work is most often cited by research in Biomaterials (295 citations), Pharmaceutical Science (100 citations), Cell Biology (166 citations), Biochemistry (53 citations) and Surfaces, Coatings and Films (51 citations). Toshiya Kai has collaborated with scholars based in Japan, Denmark and United States. Frequent co-authors include Masaki Otagiri, Ken‐ichi Ogawara, Kazutaka Higaki, Kentaro Furumoto, Makoto Anraku, Ulrich Kragh‐Hansen, Toru Maruyama, Yu Ishima, Toshikiro Kimura and Keiko Yamada. Their work appears in journals such as European Journal of Pharmaceutical Sciences, Chemical and Pharmaceutical Bulletin, International Journal of Pharmaceutics, Nitric Oxide and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.